Skip to search formSkip to main contentSkip to account menu

Ursofalk

Known as: Tramedico Brand of Ursodeoxycholic Acid, Provalis Brand of Ursodeoxycholic Acid, Orphan Brand of Ursodeoxycholic Acid 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

UrsodeoxycholateUrsodiol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Patho-physiological studies on the Reverse Effect of Curcumin (Curcuma longa, Zingiberaceae) and Ursofalk (Ursodeoxycholic acid) against the Toxicity of Carbon Tetrachloride on Albino Rats
This study, was established five groups of albino rats to determine the therapeutic effect of Curcuma longa and ursofalk against… 
2013
2013
Коррекция иммунных нарушений у больных гастроэзофагеальной рефлюксной болезнью, на фоне хронического обструктивного заболевания легких в амбулаторных условиях
The aim of the work was to study cellular link of immunity in patients with gastroesophageal refl ux disease on the background of… 
2012
2012
[Specific features of hypolipidemic therapy in patients with abdominal ischemic disease].
AIM To evaluate the efficiency and safety of combined drug therapy incorporating Ursofalk (Dr Falk Pharma GmbH, Germany) and a… 
2011
2011
Влияние препаратов урсодезоксихолевой кислоты на уровень липидов крови у больных желчекаменной болезнью
Comparative influence of ursodeoxycholic acid (Ursofalk and Ursosan) on blood lipids level in 198 patients with gallstone disease… 
2000
2000
[Treatment of primary biliary cirrhosis with ursodeoxycholic acid].
This study was undertaken to evaluate the efficacy of ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis… 
1991
1991
[The treatment of primary biliary liver cirrhosis with ursodeoxycholic acid (preliminary report)].
Seven women, mean age 47.7 years, with primary biliary cirrhosis (6 patients in the II-III stage and I patient in IV stage of the…